InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-23.0%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Ho William Tai-Wei, Chairman & CEO. Director active across 1 company, notably IN8BIO, INC.. Aggregated, 6 reports have been published. Breakdown: 2 buys · 0 sell. Total volume traded: €72k. Activity tracked since 16 August 2022. The latest transaction was disclosed on 22 December 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
36,232 shares@ US$1.38Common StockSEC:0001830914-25-000003:0
126,582 sharesCommon StockSEC:0001415889-24-024866:0
81,967 sharesCommon StockSEC:0001209191-23-058718:0
23,800 shares@ US$1.0532.0% of flowCommon StockSEC:0001209191-23-047525:0
Canonical exit: 22 Nov 2023 (T+90)
26,315 shares@ US$1.9068.0% of flowCommon StockSEC:0001209191-22-046615:0
Canonical exit: 14 Nov 2022 (T+90)
3,070 sharesCommon StockSEC:0001209191-21-049376:0
6 of 6 declarations
About Ho William Tai-Wei
Ho William Tai-Wei is the President, CEO, and CFO of IN8BIO, INC. In this role, he is responsible for the strategic and financial leadership of the company. His expertise in biotechnology and ability to lead teams are essential for achieving IN8BIO's growth and innovation objectives.
